SCCM Resource Library-Clinical Research and Epidemiology

Video Transcription

Video Summary

Dr. Rana Hijar, an intensivist at University Hospitals in Cleveland, summarized three impactful studies in intensive care. The first study, Clover's, investigated fluid strategies in ICU, raising ethical issues due to under-representation of certain patient groups and non-significant differences in outcomes, suggesting bedside assessments remain crucial in fluid management. The Cape Cod trial explored hydrocortisone use for severe community-acquired pneumonia, showing decreased mortality and ICU stay, supporting guideline recommendations for steroid use while highlighting better outcomes in certain subgroups. The third study examined Langelol, a beta-1 blocker, in septic shock patients. Despite a theoretical basis for its use, the study faced futility and safety concerns, leading to its discontinuation. Dr. Hijar emphasized the need for further research, detailed patient assessments, and careful integration of trial findings into clinical practice. Overall, these studies provide insights into improving intensive care, emphasizing physiologic considerations and personalized patient management.

Asset Caption

Year in Review | Year in Review: Research Section

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

intensive care

fluid management

hydrocortisone

septic shock

personalized medicine

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.